Lung Cancers Terminated Phase 2 Trials for Vandetanib (DB05294)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryTreatment
NCT00402896Malignant Pleural Effusion With ZD6474Treatment
NCT00290537Phase II Study of ZD6474 in Advanced NSCLCTreatment